Use of Maytenus Ilicifolia in the Treatment of Dyspepsia

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

PHASE2

Total Enrollment

4 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-02-28

Study Completion Date

2016-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to evaluate the therapeutic effect of the infusion of Maytenus ilicifolia Mart. ex Reiss leaves, used for 8 weeks, on patients with dyspepsia. Primary endpoint is SODA score, secondary endpoint is endoscopic classification (Sydney).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Trial to Reduce Inappropriate Oesophagogastroduodenoscopies for Dyspepsia

NCT03205319

Dyspepsia Indigestion

COMPLETED NA

Safety Study of a Chinese Herbal Formula Simotang Oral Liquid for the Treatment of Functional Dyspepsia

NCT01232114

Functional Dyspepsia(FD) Was Studied Effect of Simotang on FD Was Studied

UNKNOWN

Correlation Study of Atrophic Gastritis and Dyspepsia Symptoms

NCT07250308

Functional Dyspepsia Chronic Atrophic Gastritis (CAG)

RECRUITING

Symptoms and Physiological Effects of Amara in Functional Dyspepsia

NCT05553587

Dyspepsia

COMPLETED PHASE4

Observational Study on Monitoring NSAID-Induced Gastropathy in Patients Using Magnetically-Controlled Capsule Gastroscopy

NCT06027060

NSAID-Associated Gastropathy

SUSPENDED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dyspepsia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Maytenus

Tea of Martens ilicifolia leaves

Group Type EXPERIMENTAL

Maytenus ilicifolia leaves infusion

Intervention Type DRUG

2 g of powdered leaves in 150 mL of boiling water, 3 times a day, for 8 weeks

Omeprazole

Omeprazole as active comparator

Group Type ACTIVE_COMPARATOR

Omeprazole

Intervention Type DRUG

Standard therapy

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Maytenus ilicifolia leaves infusion

2 g of powdered leaves in 150 mL of boiling water, 3 times a day, for 8 weeks

Intervention Type DRUG

Omeprazole

Standard therapy

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age \> 18 years
* being literate
* diagnosis of dyspepsia
* initial SODA score \> or = 25

Exclusion Criteria

* pregnancy
* lactation
* allergy to Maytenus species
* fail to use the drug for 3 uninterrupted weeks
* new onset serious adverse events, attributable to the drug
* patient's request

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No